| Dr Andrew Jerome Riddle, DO | |
|
217 S Madison Street, Traverse, MI 49684 | |
| (231) 392-8400 | |
| (231) 935-7888 |
| Full Name | Dr Andrew Jerome Riddle |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 18 Years |
| Location | 217 S Madison Street, Traverse, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215059670 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 5101016771 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Medical Center | Traverse city, MI | Hospital |
| Charlevoix Area Hospital | Charlevoix, MI | Hospital |
| Kalkaska Memorial Health Center | Kalkaska, MI | Hospital |
| Paul Oliver Memorial Hospital | Frankfort, MI | Hospital |
| Munson Healthcare Cadillac Hospital | Cadillac, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Munson Medical Center | 3072426287 | 257 |
News Archive
Formation of new blood vessels, a process also known as angiogenesis, is one of the major clinical challenges in wound healing and tissue implants. To address this issue, researchers from Texas A&M University have developed a clay-based platform to deliver therapeutic proteins to the body to assist with the formation of blood vessels.
Luna Innovations Incorporated (NASDAQ:LUNA), a company focusing on sensing & instrumentation and pharmaceutical nanomedicines, today announced that the Company has received a letter from The NASDAQ Stock Market indicating that because the bid price of the Company's common stock closed below the minimum $1.00 per share threshold set forth in NASDAQ Listing Rule 5550(a)(2) for the prior 30 consecutive business days, the Company has been provided 180 calendar days, or until March 15, 2010, to regain compliance with the minimum bid price requirement.
In a study presented at the on-going ESHRE conference in Istanbul, Vitrolife's patent protected medium EmbryoGlue has once again been proven to increase both implantation and pregnancy rates, regardless of hormone stimulation of the endometrium or not.
The environment has a more formidable opponent than carbon dioxide. Another greenhouse gas, nitrous oxide, is 300 times more potent and also destroys the ozone layer each time it is released into the atmosphere through agricultural practices, sewage treatment and fossil fuel combustion.
› Verified 1 days ago
| Entity Name | Munson Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083761860 PECOS PAC ID: 3072426287 Enrollment ID: O20040108000904 |
News Archive
Formation of new blood vessels, a process also known as angiogenesis, is one of the major clinical challenges in wound healing and tissue implants. To address this issue, researchers from Texas A&M University have developed a clay-based platform to deliver therapeutic proteins to the body to assist with the formation of blood vessels.
Luna Innovations Incorporated (NASDAQ:LUNA), a company focusing on sensing & instrumentation and pharmaceutical nanomedicines, today announced that the Company has received a letter from The NASDAQ Stock Market indicating that because the bid price of the Company's common stock closed below the minimum $1.00 per share threshold set forth in NASDAQ Listing Rule 5550(a)(2) for the prior 30 consecutive business days, the Company has been provided 180 calendar days, or until March 15, 2010, to regain compliance with the minimum bid price requirement.
In a study presented at the on-going ESHRE conference in Istanbul, Vitrolife's patent protected medium EmbryoGlue has once again been proven to increase both implantation and pregnancy rates, regardless of hormone stimulation of the endometrium or not.
The environment has a more formidable opponent than carbon dioxide. Another greenhouse gas, nitrous oxide, is 300 times more potent and also destroys the ozone layer each time it is released into the atmosphere through agricultural practices, sewage treatment and fossil fuel combustion.
› Verified 1 days ago
| Entity Name | Munson Healthcare Charlevoix Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326124058 PECOS PAC ID: 4284528035 Enrollment ID: O20040211001170 |
News Archive
Formation of new blood vessels, a process also known as angiogenesis, is one of the major clinical challenges in wound healing and tissue implants. To address this issue, researchers from Texas A&M University have developed a clay-based platform to deliver therapeutic proteins to the body to assist with the formation of blood vessels.
Luna Innovations Incorporated (NASDAQ:LUNA), a company focusing on sensing & instrumentation and pharmaceutical nanomedicines, today announced that the Company has received a letter from The NASDAQ Stock Market indicating that because the bid price of the Company's common stock closed below the minimum $1.00 per share threshold set forth in NASDAQ Listing Rule 5550(a)(2) for the prior 30 consecutive business days, the Company has been provided 180 calendar days, or until March 15, 2010, to regain compliance with the minimum bid price requirement.
In a study presented at the on-going ESHRE conference in Istanbul, Vitrolife's patent protected medium EmbryoGlue has once again been proven to increase both implantation and pregnancy rates, regardless of hormone stimulation of the endometrium or not.
The environment has a more formidable opponent than carbon dioxide. Another greenhouse gas, nitrous oxide, is 300 times more potent and also destroys the ozone layer each time it is released into the atmosphere through agricultural practices, sewage treatment and fossil fuel combustion.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Jerome Riddle, DO 2513 Momentum Pl, Chicago, IL 60689-5325 Ph: (231) 935-6080 | Dr Andrew Jerome Riddle, DO 217 S Madison Street, Traverse, MI 49684 Ph: (231) 392-8400 |
News Archive
Formation of new blood vessels, a process also known as angiogenesis, is one of the major clinical challenges in wound healing and tissue implants. To address this issue, researchers from Texas A&M University have developed a clay-based platform to deliver therapeutic proteins to the body to assist with the formation of blood vessels.
Luna Innovations Incorporated (NASDAQ:LUNA), a company focusing on sensing & instrumentation and pharmaceutical nanomedicines, today announced that the Company has received a letter from The NASDAQ Stock Market indicating that because the bid price of the Company's common stock closed below the minimum $1.00 per share threshold set forth in NASDAQ Listing Rule 5550(a)(2) for the prior 30 consecutive business days, the Company has been provided 180 calendar days, or until March 15, 2010, to regain compliance with the minimum bid price requirement.
In a study presented at the on-going ESHRE conference in Istanbul, Vitrolife's patent protected medium EmbryoGlue has once again been proven to increase both implantation and pregnancy rates, regardless of hormone stimulation of the endometrium or not.
The environment has a more formidable opponent than carbon dioxide. Another greenhouse gas, nitrous oxide, is 300 times more potent and also destroys the ozone layer each time it is released into the atmosphere through agricultural practices, sewage treatment and fossil fuel combustion.
› Verified 1 days ago